Screener/Healthcare/Biotechnology

CRVS

Corvus Pharmaceuticals, Inc.NASDAQ
$13.18-0.56 (-4.07%)
Small CapUnder $20Healthcare
$2.54
$26.95
$12.98
$13.82
EPS (TTM)$-0.51
P/E Ratio—
Dividend Yield—
Market Cap$1.34B
Volume854K
Prev Close$13.75
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$0-$10.2M$-0.12——
Q2 '25$0-$8.0M$-0.10——
Q1 '25$0$15.2M$-0.13——
Q4 '24$0-$12.1M$-0.16——
Q3 '24$0-$40.2M$-0.60——
Q2 '24$0-$4.3M$-0.07——
Q1 '24$0-$5.7M$-0.12——
Q4 '23$0-$6.7M$-0.13——
Get Your Daily Market Recap